Safety and Efficacy of Fingolimod in MS Patients in China

Clinical trial NCT01941004 · WITHDRAWN

Trial details

NCT number: NCT01941004
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis (Relapsing Remitting)

Start date: 2014-06-01
Primary completion: 2017-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.